Insiders · SXTP

SXTP insider transactions

60 Degrees Pharmaceuticals Inc. (SXTP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SXTP

• 15d
  SEC Form 3 filed by new insider Francois Eric

  3 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 168d
  President and CEO Dow Geoffrey S bought $7,759 worth of shares (9,670 units at $0.80), increasing direct ownership by 19% to 59,618 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 173d
  President and CEO Dow Geoffrey S bought $12,204 worth of shares (12,963 units at $0.94), increasing direct ownership by 35% to 49,948 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 261d
  President and CEO Dow Geoffrey S was granted 7,201 shares, increasing direct ownership by 28% to 33,372 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 292d
  SEC Form 4 filed by Chief Operating Officer Landon Kristen

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 292d
  Chief Operating Officer Landon Kristen was granted 4,540 shares (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 292d
  SEC Form 3 filed by new insider Landon Kristen

  3 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 359d
  President and CEO Dow Geoffrey S was granted 4,376 shares, increasing direct ownership by 20% to 26,171 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 362d
  Director Xu Cheryl bought $14,410 worth of shares (5,000 units at $2.88), increasing direct ownership by 46% to 15,816 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 495d
  SEC Form 4 filed by President and CEO Dow Geoffrey S

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 495d
  SEC Form 4 filed by CFO Miller Tyrone

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 498d
  President and CEO Dow Geoffrey S was granted 14,394 shares, increasing direct ownership by 15% to 108,974 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 498d
  CFO Miller Tyrone was granted 11,626 shares, increasing direct ownership by 79% to 26,370 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 531d
  Director Xu Cheryl bought $21,400 worth of shares (13,000 units at $1.65), increasing direct ownership by 32% to 54,078 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 541d
  President and CEO Dow Geoffrey S bought $89,755 worth of shares (73,951 units at $1.21), increasing direct ownership by 358% to 94,580 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 558d
  President and CEO Dow Geoffrey S bought $6,367 worth of shares (7,000 units at $0.91), increasing direct ownership by 51% to 20,629 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 630d
  Director Xu Cheryl bought $8,500 worth of shares (5,000 units at $1.70), increasing direct ownership by 14% to 41,078 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Xu Cheryl exercised 2,000 shares at a strike of $0.22, increasing direct ownership by 0.88% to 228,934 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Toovey Stephen was granted 4,000 shares, increasing direct ownership by 40% to 14,000 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Miller Tyrone was granted 75,000 shares, increasing direct ownership by 74% to 176,928 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Field Paul exercised 4,000 shares at a strike of $0.22, increasing direct ownership by 40% to 14,000 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Dow Geoffrey S exercised 85,000 shares at a strike of $0.26 (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 742d
  Allen Charles W exercised 4,000 shares at a strike of $0.22, increasing direct ownership by 40% to 14,000 units (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)
• 791d
  Knight Therapeutics Inc converted options into 45,560 shares (SEC Form 4)

  4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)